Evan Lippman
Corporate Officer/Principal presso ALNYLAM PHARMACEUTICALS, INC.
Profilo
Evan Lippman is currently the Chief Corporate Development & Strategy Officer at Alnylam Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior VP, Chief Financial & Business Officer at Aileron Therapeutics, Inc. from 2015 to 2016.
He also served as the Senior Vice President-Neurodegenerative Diseases at EMD Serono, Inc. and as the President & Chief Operating Officer at Intima Bioscience, Inc. Mr. Lippman completed his undergraduate studies at Bucknell University and Georgia State University.
He holds an MBA from Cornell University.
Posizioni attive di Evan Lippman
Società | Posizione | Inizio |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/09/2022 |
Precedenti posizioni note di Evan Lippman
Società | Posizione | Fine |
---|---|---|
AILERON THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/12/2016 |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Presidente | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Formazione di Evan Lippman
Bucknell University | Undergraduate Degree |
Georgia State University | Undergraduate Degree |
Cornell University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Evan Lippman